GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 12 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $154,000 | -42.8% | 36,172 | -44.0% | 0.00% | -40.0% |
| Q1 2021 | $269,000 | +15.5% | 64,600 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $233,000 | +4.0% | 64,600 | 0.0% | 0.00% | -42.9% |
| Q3 2020 | $224,000 | +52.4% | 64,600 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $147,000 | – | 64,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 13,357 | $41,000 | 0.00% |
| BREWIN DOLPHIN LTD | 20 | $62 | 0.00% |
| ROYAL BANK OF CANADA | 3,000 | $9,000 | 0.00% |
| UBS Group AG | 75 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 62,408 | $193,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 17,199 | $53,000 | 0.00% |
| MORGAN STANLEY | 30,113 | $93,000 | 0.00% |
| Citadel Advisors | 28,500 | $88,000 | 0.00% |
| Citadel Advisors | 21,500 | $66,000 | 0.00% |